P38. Defining involved circumferential resection margins in oesophageal cancer

Bilal Alkhaffaf; Edward Massa; Jeremy Ward; Kishore Pursnani; Paul Turner

doi:10.1016/j.ejso.2012.07.159

P38. Defining involved circumferential resection margins in oesophageal cancer

Bilal Alkhaffaf, Edward Massa, Jeremy Ward, Kishore Pursnani, Paul Turner

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Background: The circumferential resection margin (CRM) in oesophageal cancer is an important prognostic factor, however the definition of what constitutes an involved CRM remains contentious. The Royal College of Physicians defines an involved CRM as the presence of tumour cells within 1mm of the cut edge of the specimen, whereas the College of American Pathologists considers an involved CRM only when tumour cells are present at the cut edge. The aim of this study was to determine whether there was a difference between these two definitions in terms of early recurrence and survival.

Original language	Undefined
Article number	P38
Pages (from-to)	P1116
Number of pages	1
Journal	European Journal of Surgical Oncology (EJSO)
Volume	38
Issue number	11
DOIs	https://doi.org/10.1016/j.ejso.2012.07.159
Publication status	Published - 1 Nov 2012

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejso.2012.07.159

Cite this

@article{3cec0c2b3a2947449b53981c8852d01f,

title = "P38. Defining involved circumferential resection margins in oesophageal cancer",

abstract = "Background: The circumferential resection margin (CRM) in oesophageal cancer is an important prognostic factor, however the definition of what constitutes an involved CRM remains contentious. The Royal College of Physicians defines an involved CRM as the presence of tumour cells within 1mm of the cut edge of the specimen, whereas the College of American Pathologists considers an involved CRM only when tumour cells are present at the cut edge. The aim of this study was to determine whether there was a difference between these two definitions in terms of early recurrence and survival.",

author = "Bilal Alkhaffaf and Edward Massa and Jeremy Ward and Kishore Pursnani and Paul Turner",

year = "2012",

month = nov,

day = "1",

doi = "10.1016/j.ejso.2012.07.159",

language = "Undefined",

volume = "38",

pages = "P1116",

journal = "European Journal of Surgical Oncology (EJSO)",

issn = "0748-7983",

publisher = "W.B. Saunders Co. Ltd",

number = "11",

}

TY - JOUR

T1 - P38. Defining involved circumferential resection margins in oesophageal cancer

AU - Alkhaffaf, Bilal

AU - Massa, Edward

AU - Ward, Jeremy

AU - Pursnani, Kishore

AU - Turner, Paul

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Background: The circumferential resection margin (CRM) in oesophageal cancer is an important prognostic factor, however the definition of what constitutes an involved CRM remains contentious. The Royal College of Physicians defines an involved CRM as the presence of tumour cells within 1mm of the cut edge of the specimen, whereas the College of American Pathologists considers an involved CRM only when tumour cells are present at the cut edge. The aim of this study was to determine whether there was a difference between these two definitions in terms of early recurrence and survival.

AB - Background: The circumferential resection margin (CRM) in oesophageal cancer is an important prognostic factor, however the definition of what constitutes an involved CRM remains contentious. The Royal College of Physicians defines an involved CRM as the presence of tumour cells within 1mm of the cut edge of the specimen, whereas the College of American Pathologists considers an involved CRM only when tumour cells are present at the cut edge. The aim of this study was to determine whether there was a difference between these two definitions in terms of early recurrence and survival.

U2 - 10.1016/j.ejso.2012.07.159

DO - 10.1016/j.ejso.2012.07.159

M3 - Meeting Abstract

SN - 0748-7983

VL - 38

SP - P1116

JO - European Journal of Surgical Oncology (EJSO)

JF - European Journal of Surgical Oncology (EJSO)

IS - 11

M1 - P38

ER -